JP2003277346A - Method for producing optically active sulfonamide compound - Google Patents
Method for producing optically active sulfonamide compoundInfo
- Publication number
- JP2003277346A JP2003277346A JP2002082509A JP2002082509A JP2003277346A JP 2003277346 A JP2003277346 A JP 2003277346A JP 2002082509 A JP2002082509 A JP 2002082509A JP 2002082509 A JP2002082509 A JP 2002082509A JP 2003277346 A JP2003277346 A JP 2003277346A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- optically active
- compound represented
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 sulfonamide compound Chemical class 0.000 title claims abstract description 103
- 229940124530 sulfonamide Drugs 0.000 title claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 31
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 150000004678 hydrides Chemical class 0.000 claims abstract description 9
- 150000004700 cobalt complex Chemical class 0.000 claims abstract description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims description 30
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 7
- 238000006722 reduction reaction Methods 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000001153 fluoro group Chemical group F* 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 4
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 238000011946 reduction process Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- DIKBFYAXUHHXCS-UHFFFAOYSA-N bromoform Chemical compound BrC(Br)Br DIKBFYAXUHHXCS-UHFFFAOYSA-N 0.000 description 4
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 4
- 150000002366 halogen compounds Chemical class 0.000 description 4
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 2
- 229950005228 bromoform Drugs 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- JAWGVVJVYSANRY-UHFFFAOYSA-N cobalt(3+) Chemical compound [Co+3] JAWGVVJVYSANRY-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 239000003759 ester based solvent Substances 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- 125000005956 isoquinolyl group Chemical group 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 125000005493 quinolyl group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JONIMGVUGJVFQD-UHFFFAOYSA-N (4-methylphenyl)sulfonylformonitrile Chemical compound CC1=CC=C(S(=O)(=O)C#N)C=C1 JONIMGVUGJVFQD-UHFFFAOYSA-N 0.000 description 1
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000003469 3-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 101100214874 Autographa californica nuclear polyhedrosis virus AC81 gene Proteins 0.000 description 1
- CAHQGWAXKLQREW-UHFFFAOYSA-N Benzal chloride Chemical compound ClC(Cl)C1=CC=CC=C1 CAHQGWAXKLQREW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 101001034314 Homo sapiens Lactadherin Proteins 0.000 description 1
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100039648 Lactadherin Human genes 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- DKENIBCTMGZSNM-UHFFFAOYSA-N benzenesulfinyl chloride Chemical compound ClS(=O)C1=CC=CC=C1 DKENIBCTMGZSNM-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- JOHCVVJGGSABQY-UHFFFAOYSA-N carbon tetraiodide Chemical compound IC(I)(I)I JOHCVVJGGSABQY-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- QCRFMSUKWRQZEM-UHFFFAOYSA-N cycloheptanol Chemical compound OC1CCCCCC1 QCRFMSUKWRQZEM-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 description 1
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- HKMLRUAPIDAGIE-UHFFFAOYSA-N methyl 2,2-dichloroacetate Chemical compound COC(=O)C(Cl)Cl HKMLRUAPIDAGIE-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- ROTONRWJLXYJBD-UHFFFAOYSA-N oxan-2-ylmethanol Chemical compound OCC1CCCCO1 ROTONRWJLXYJBD-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 125000005920 sec-butoxy group Chemical group 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、医薬品などの生理
活性化合物の合成中間体または原体として有用な光学活
性なスルホンアミド化合物をエナンチオ選択的に製造す
る方法に関する。TECHNICAL FIELD The present invention relates to a method for enantioselectively producing an optically active sulfonamide compound useful as a synthetic intermediate or drug substance for a physiologically active compound such as a drug.
【0002】[0002]
【従来の技術】光学活性なスルホンアミド化合物は医薬
品の合成原料や中間体として用いられる重要な化合物で
ある。例えば、特開平10−195038号公報には、
トロンボキサンA2拮抗作用およびロイコトリエンD4拮
抗作用を併せ持つ、式(c):BACKGROUND OF THE INVENTION Optically active sulfonamide compounds are important compounds used as synthetic raw materials and intermediates for pharmaceuticals. For example, in Japanese Patent Laid-Open No. 10-195038,
Formula (c) having both thromboxane A 2 antagonism and leukotriene D 4 antagonism:
【0003】[0003]
【化6】 [Chemical 6]
【0004】(式中、R1は炭素数4〜8の直鎖状また
は分岐鎖状アルキル基、1個または複数個のフッ素原子
が置換した炭素数4〜8の直鎖状または分岐鎖状のアル
キル基を表し、R2は水素原子または低級アルキル基を
表し、R3は水素原子、ハロゲン原子、低級アルキル
基、低級アルコキシ基またはニトロ基を表す。)で示さ
れる光学活性なスルホンアミド化合物が開示されてい
る。このスルホンアミド化合物は、例えば血小板凝集抑
制剤、抗血栓剤、抗喘息剤及び抗アレルギー剤としての
有効性が期待され、開発が進められている化合物であ
る。この化合物は、下記反応式(I)で示す工程に従っ
て製造できることが報告されている(特開平2001−
11033)。
反応式(I):(In the formula, R 1 is a straight-chain or branched-chain alkyl group having 4-8 carbon atoms, or a straight-chain or branched-chain group having 4-8 carbon atoms substituted with one or more fluorine atoms. Is an alkyl group, R 2 is a hydrogen atom or a lower alkyl group, and R 3 is a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group or a nitro group.). Is disclosed. This sulfonamide compound is a compound which is expected to be effective as a platelet aggregation inhibitor, an antithrombotic agent, an antiasthma agent and an antiallergic agent, and is under development. It has been reported that this compound can be produced according to the process represented by the following reaction formula (I) (Japanese Patent Laid-Open No. 2001-2001).
11033). Reaction formula (I):
【0005】[0005]
【化7】 [Chemical 7]
【0006】この方法によれば、式(a)で示されるケ
トン化合物を不斉還元して、式(f)で示される光学活
性なアルコールに変換し、該アルコールの水酸基を置換
して窒素置換基を導入することによって、式(c)で示
される目的物が合成できる。しかし、この工程において
は、式(f)で示されるアルコール化合物、式(g)で
示されるトリフルオロ酢酸エステル化合物、式(h)で
示されるアジド化合物等を経由し、式(c)で示される
目的物中に含まれない官能基の導入、脱離反応を行うた
め、工程数が多くなり必ずしも効率のよい方法とはいえ
ない。また、式(h)で示される、爆発の危険性のある
アジド化合物を利用する点で、安全性に問題がある。According to this method, the ketone compound represented by the formula (a) is asymmetrically reduced to be converted into the optically active alcohol represented by the formula (f), and the hydroxyl group of the alcohol is substituted to substitute nitrogen. By introducing the group, the target compound represented by the formula (c) can be synthesized. However, in this step, the alcohol compound represented by the formula (f), the trifluoroacetic acid ester compound represented by the formula (g), the azide compound represented by the formula (h), etc. are passed through and the compound represented by the formula (c) is represented. Since a functional group which is not contained in the target substance is introduced and eliminated, the number of steps is increased and the method is not always efficient. Further, there is a problem in safety in using the azide compound represented by the formula (h) and having a risk of explosion.
【0007】[0007]
【発明が解決しようとする課題】本発明の目的は、従来
技術における問題点を解決し、工程数の少ない安全で簡
便な方法を用い、高収率でエナンチオ選択的に前記式
(c)で示されるスルホンアミド化合物を製造する方法
を提供することにある。The object of the present invention is to solve the problems in the prior art, to use a safe and simple method with a small number of steps, and enantioselectively with the above formula (c) in a high yield. It is to provide a method for producing the indicated sulfonamide compound.
【0008】[0008]
【課題を解決するための手段】本発明者らは鋭意検討を
重ねた結果、スルホンイミド化合物の不斉還元反応を行
う工程を経由する簡便な方法により、優れた収率でエナ
ンチオ選択的に目的物が得られることを見出し、前記目
的を達成した。Means for Solving the Problems As a result of intensive studies by the present inventors, as a result of a simple method involving a step of carrying out an asymmetric reduction reaction of a sulfonimide compound, an enantioselective purpose with excellent yield was obtained. It was found that a product was obtained, and the above-mentioned object was achieved.
【0009】すなわち本発明は、下記反応式(II):That is, the present invention provides the following reaction formula (II):
【0010】[0010]
【化8】 [Chemical 8]
【0011】に示すように、(1)式(a)で示される
ケトン化合物をスルホンイミド化合物に変換する工程
(工程1)、(2)生成する式(b)で示されるスルホ
ンイミド化合物を不斉還元反応する工程(工程2)から
なる、式(c)で示されるスルホンアミド化合物を製造
する方法である。前記工程2において、光学活性コバル
ト錯体触媒存在下、ヒドリド試薬を用いて不斉還元反応
を行うことが好ましい。As shown in (1), the step (1) of converting the ketone compound represented by the formula (a) into a sulfonimide compound (step 1), and (2) the sulfonimide compound represented by the formula (b) is not generated. A method for producing a sulfonamide compound represented by the formula (c), which comprises a step (step 2) of simultaneous reduction reaction. In the step 2, it is preferable to carry out the asymmetric reduction reaction using a hydride reagent in the presence of an optically active cobalt complex catalyst.
【0012】[0012]
【発明の実施の形態】以下、本発明のスルホンアミド化
合物の製造方法(以下、「本発明の方法」という)につ
いて詳細に説明する。
[工程1:ケトン化合物をスルホニルイミノ化する反
応]
式(a):BEST MODE FOR CARRYING OUT THE INVENTION The method for producing the sulfonamide compound of the present invention (hereinafter referred to as "the method of the present invention") will be described in detail below. [Step 1: Reaction of Sulfonyliminating Ketone Compound] Formula (a):
【0013】[0013]
【化9】 [Chemical 9]
【0014】で示されるケトン化合物から、式(b):From the ketone compound represented by the formula (b):
【0015】[0015]
【化10】 [Chemical 10]
【0016】で示されるスルホンイミド化合物を製造す
る工程1は、以下、(方法1)〜(方法3)の既存の方
法により行うことができる。
(方法1) 式(a)で示されるケトン化合物を溶媒
中、塩基存在下、ヒドロキシアミン又はその塩と反応さ
せることによって、式(k):Step 1 for producing the sulfonimide compound represented by can be carried out by the following existing methods (method 1) to (method 3). (Method 1) A ketone compound represented by the formula (a) is reacted with hydroxyamine or a salt thereof in a solvent in the presence of a base to give a compound of the formula (k):
【0017】[0017]
【化11】 [Chemical 11]
【0018】で示されるオキシム化合物を生成させ、得
られた式(k)で示されるオキシム化合物を溶媒中、塩
基存在下、式(l):An oxime compound represented by the formula (1):
【0019】[0019]
【化12】 [Chemical 12]
【0020】で示される塩化ベンゼンスルフィニル化合
物、または式(m):A benzenesulfinyl chloride compound represented by: or a compound of formula (m):
【0021】[0021]
【化13】 [Chemical 13]
【0022】で示されるベンゼンスルホニルシアニド化
合物と反応させることにより、式(b)で示されるスル
ホンイミド化合物を得る方法(Dale L. Boge
r,J. Org. Chem. 1992, 57, 4
777.)。
(方法2) 式(a)で示されるケトン化合物を溶媒
中、あらかじめn−ブチルリチウムで処理したヘキサメ
チルジシラザンリチウム塩と反応させることによって、
式(n):A method for obtaining a sulfonimide compound represented by the formula (b) by reacting with a benzenesulfonyl cyanide compound represented by (Dale L. Bage)
r, J. Org. Chem. 1992, 57, 4
777. ). (Method 2) By reacting a ketone compound represented by the formula (a) with a hexamethyldisilazane lithium salt previously treated with n-butyllithium in a solvent,
Formula (n):
【0023】[0023]
【化14】 [Chemical 14]
【0024】で示されるトリメチルシリルイミン化合物
を生成させ、得られた式(n)で示されるトリメチルシリ
ルイミン化合物を溶媒中、式(j):A trimethylsilylimine compound represented by formula (j) is produced, and the obtained trimethylsilylimine compound represented by formula (n) is added to a solvent of formula (j):
【0025】[0025]
【化15】 [Chemical 15]
【0026】で示される塩化スルホニル化合物と反応さ
せることにより、式(b)で示されるスルホンイミド化
合物を得る方法(Gunda I. Georg, J.
Org. Chem., 1995, 60(22), 7
366.)。
(方法3) 式(a)で示されるケトン化合物を溶媒
中、テトラエトキシシラン存在下、式(o):A method for obtaining a sulfonimide compound represented by the formula (b) by reacting with a sulfonyl chloride compound represented by (Gunda I. Georg, J. et al.
Org. Chem. , 1995, 60 (22), 7
366. ). (Method 3) In the presence of tetraethoxysilane in a solvent, a ketone compound represented by the formula (a) is prepared by the formula (o):
【0027】[0027]
【化16】 [Chemical 16]
【0028】で示されるベンゼンスルホンアミド化合物
と反応させることによって、式(b)で示されるスルホ
ンイミド化合物を得る方法(Brian E. Lov
e, Synlett. 1994, 493.)。式
(a)、式(b)、式(c)、式(k)、式(n)中、
R1は炭素数4〜8の直鎖状または分岐鎖状アルキル
基、1個または複数個のフッ素原子が置換した炭素数4
〜8の直鎖状または分岐鎖状のアルキル基を表す。A method for obtaining a sulfonimide compound represented by the formula (b) by reacting with a benzenesulfonamide compound represented by (Brian E. Lov.
e, Synlett. 1994, 493. ). In formula (a), formula (b), formula (c), formula (k), and formula (n),
R 1 is a linear or branched alkyl group having 4 to 8 carbon atoms, or 4 carbon atoms substituted with one or more fluorine atoms.
~ 8 represents a straight chain or branched chain alkyl group.
【0029】炭素数4〜8の直鎖状または分岐鎖状アル
キル基としては、例えば、n−ブチル基、sec−ブチ
ル基、tert−ブチル基、n−ペンチル基、1−メチ
ルブチル基、2−メチルブチル基、3−メチルブチル
基、1−エチルブチル基、n−ヘキシル基、2−メチル
ペンチル基、3−メチルペンチル基、4−メチルペンチ
ル基、n−ヘプチル基、2−メチルヘキシル基、3−メ
チルヘキシル基、4−メチルヘキシル基、5−メチルヘ
キシル基、n−オクチル基、2−メチルヘプチル基、3
−メチルヘプチル基、4−メチルヘプチル基、5−メチ
ルヘプチル基、6−メチルヘプチル基等が挙げられる。Examples of the linear or branched alkyl group having 4 to 8 carbon atoms include n-butyl group, sec-butyl group, tert-butyl group, n-pentyl group, 1-methylbutyl group and 2- Methylbutyl group, 3-methylbutyl group, 1-ethylbutyl group, n-hexyl group, 2-methylpentyl group, 3-methylpentyl group, 4-methylpentyl group, n-heptyl group, 2-methylhexyl group, 3-methyl Hexyl group, 4-methylhexyl group, 5-methylhexyl group, n-octyl group, 2-methylheptyl group, 3
-Methylheptyl group, 4-methylheptyl group, 5-methylheptyl group, 6-methylheptyl group and the like can be mentioned.
【0030】1個または複数個のフッ素原子が置換した
炭素数4〜8の直鎖状または分岐鎖状のアルキル基とし
ては、例えば、4−フルオロブチル基、5−フルオロペ
ンチル基、6−フルオロヘキシル基、4,4−ジフルオ
ロブチル基、5,5−ジフルオロペンチル基、6,6−
ジフルオロヘキシル基、4,4,4−トリフルオロブチ
ル基、5,5,5−トリフルオロペンチル基、6,6,
6−トリフルオロヘキシル基、7,7,7−トリフルオ
ロヘプチル基、4,4,4−トリフルオロ−3−メチル
ブチル基、5,5,5−トリフルオロ−4−メチルペン
チル基、6,6,6−トリフルオロ−5−メチルヘキシ
ル基、3,3,4,4,4−ペンタフルオロブチル基、
4,4,5,5,5−ペンタフルオロペンチル基、5,
5,6,6,6−ペンタフルオロヘキシル基、6,6,
7,7,7−ペンタフルオロヘプチル基、3,3,4,
4,5,5,5−ヘプタフルオロペンチル基、4,4,
5,5,6,6,6−ヘプタフルオロヘキシル基、5,
5,6,6,7,7,7−ヘプタフルオロヘプチル基、
3,3,4,4,5,5,6,6,6−ノナフルオロヘ
キシル基、4,4,5,5,6,6,7,7,7−ノナ
フルオロヘプチル基、3,3,4,4,5,5,6,
6,7,7,7−ウンデカフルオロヘプチル基、3,
3,4,4,5,5,6,6,7,7,8,8,8−ト
リデカフルオロオクチル基、4,4,4−トリフルオロ
−3−トリフルオロメチルブチル基、Examples of the linear or branched alkyl group having 4 to 8 carbon atoms in which one or more fluorine atoms are substituted include, for example, 4-fluorobutyl group, 5-fluoropentyl group and 6-fluoro group. Hexyl group, 4,4-difluorobutyl group, 5,5-difluoropentyl group, 6,6-
Difluorohexyl group, 4,4,4-trifluorobutyl group, 5,5,5-trifluoropentyl group, 6,6
6-trifluorohexyl group, 7,7,7-trifluoroheptyl group, 4,4,4-trifluoro-3-methylbutyl group, 5,5,5-trifluoro-4-methylpentyl group, 6,6 , 6-trifluoro-5-methylhexyl group, 3,3,4,4,4-pentafluorobutyl group,
4,4,5,5,5-pentafluoropentyl group, 5,
5,6,6,6-pentafluorohexyl group, 6,6
7,7,7-pentafluoroheptyl group, 3,3,4
4,5,5,5-heptafluoropentyl group, 4,4
5,5,6,6,6-heptafluorohexyl group, 5,
5,6,6,7,7,7-heptafluoroheptyl group,
3,3,4,4,5,5,6,6,6-nonafluorohexyl group, 4,4,5,5,6,6,7,7,7-nonafluoroheptyl group, 3,3,3 4, 4, 5, 5, 6,
6,7,7,7-undecafluoroheptyl group, 3,
3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl group, 4,4,4-trifluoro-3-trifluoromethylbutyl group,
【0031】5,5,5−トリフルオロ−4−トリフル
オロメチルペンチル基、6,6,6−トリフルオロ−5
−トリフルオロメチルヘキシル基、3,4,4,4−テ
トラフルオロ−3−トリフルオロメチルブチル基、4,
5,5,5−テトラフルオロ−4−トリフルオロメチル
ペンチル基、5,6,6,6−テトラフルオロ−5−ト
リフルオロメチルヘキシル基、3,3,4,5,5,5
−ヘキサフルオロ−4−トリフルオロメチルペンチル
基、4,4,5,6,6,6−ヘキサフルオロ−5−ト
リフルオロメチルヘキシル基、3,4,4,5,5,5
−ヘキサフルオロ−3−トリフルオロメチルペンチル
基、3,3,4,4,5,6,6,6−オクタフルオロ
−5−トリフルオロメチルヘキシル基、5,5,5−ト
リフルオロ−4,4−ビス(トリフルオロメチル)ペン
チル基、6,6,6−トリフルオロ−5,5−ビス(ト
リフルオロメチル)ヘキシル基、4,4,5,5,6,
6,6−ヘプタフルオロ−3,3−ビス(トリフルオロ
メチル)ヘキシル基等が挙げられる。5,5,5-trifluoro-4-trifluoromethylpentyl group, 6,6,6-trifluoro-5
-Trifluoromethylhexyl group, 3,4,4,4-tetrafluoro-3-trifluoromethylbutyl group, 4,
5,5,5-tetrafluoro-4-trifluoromethylpentyl group, 5,6,6,6-tetrafluoro-5-trifluoromethylhexyl group, 3,3,4,5,5,5
-Hexafluoro-4-trifluoromethylpentyl group, 4,4,5,6,6,6-hexafluoro-5-trifluoromethylhexyl group, 3,4,4,5,5,5
-Hexafluoro-3-trifluoromethylpentyl group, 3,3,4,4,5,6,6,6-octafluoro-5-trifluoromethylhexyl group, 5,5,5-trifluoro-4,4 -Bis (trifluoromethyl) pentyl group, 6,6,6-trifluoro-5,5-bis (trifluoromethyl) hexyl group, 4,4,5,5,6
6,6-heptafluoro-3,3-bis (trifluoromethyl) hexyl group and the like can be mentioned.
【0032】R2は水素原子または低級アルキル基を表
す。低級アルキル基としては、例えば、メチル基、エチ
ル基、n−プロピル基、イソプロピル基、n−ブチル
基、sec−ブチル基、tert−ブチル基等が挙げら
れる。R 2 represents a hydrogen atom or a lower alkyl group. Examples of the lower alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a sec-butyl group, a tert-butyl group and the like.
【0033】R3は水素原子、ハロゲン原子、低級アル
キル基、低級アルコキシまたはニトロ基を表す。ハロゲ
ン原子としては、例えば、フッ素原子、塩素原子、臭素
原子、ヨウ素原子が挙げられる。R 3 represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy or a nitro group. Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
【0034】低級アルキル基としては、例えば、メチル
基、エチル基、n−プロピル基、イソプロピル基、n−
ブチル基、sec−ブチル基、tert−ブチル基等が
挙げられる。低級アルコキシ基としては、 メトキシ
基、エトキシ基、n−プロポキシ基、イソプロポキシ
基、n−ブトキシ基、sec−ブトキシ基、tert−
ブトキシ基等が挙げられる。As the lower alkyl group, for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-
Examples thereof include a butyl group, a sec-butyl group and a tert-butyl group. The lower alkoxy group includes methoxy group, ethoxy group, n-propoxy group, isopropoxy group, n-butoxy group, sec-butoxy group, tert-group.
Examples thereof include butoxy group.
【0035】[工程2:スルホンイミド化合物の不斉還
元反応] 工程1により得られた式(b)で示される化
合物を、光学活性コバルト錯体触媒存在下、ヒドリド試
薬と反応させることによって、式(c):[Step 2: Asymmetric reduction reaction of sulfonimide compound] By reacting the compound represented by the formula (b) obtained in the step 1 with a hydride reagent in the presence of an optically active cobalt complex catalyst, the formula ( c):
【0036】[0036]
【化17】 [Chemical 17]
【0037】で示される、スルホンアミド化合物を得る
ことができる。A sulfonamide compound represented by can be obtained.
【0038】触媒として用いられる光学活性コバルト錯
体としては、特開平9−151143号公報に開示され
ている下記一般式(d):As the optically active cobalt complex used as a catalyst, the following general formula (d) disclosed in JP-A-9-151143:
【0039】[0039]
【化18】 [Chemical 18]
【0040】で表される光学活性コバルト(II)錯体
が用いられる。An optically active cobalt (II) complex represented by the following is used.
【0041】この光学活性コバルト錯体を表す前記一般
式(d)において、R4とR5は異なる基であり、それぞ
れ、水素原子、直鎖もしくは分岐鎖状のアルキル基、ア
リール基または芳香族複素環基であり、これらは置換基
を有していてもよい。この直鎖または分岐鎖状のアルキ
ル基としては、メチル基、エチル基、n−プロピル基、
イソプロピル基、n−ブチル基、sec−ブチル基、t
ert−ブチル基等が代表的である。In the general formula (d) representing the optically active cobalt complex, R 4 and R 5 are different groups, and each is a hydrogen atom, a linear or branched alkyl group, an aryl group or an aromatic heterocyclic group. It is a cyclic group, and these may have a substituent. Examples of the linear or branched alkyl group include a methyl group, an ethyl group, an n-propyl group,
Isopropyl group, n-butyl group, sec-butyl group, t
A typical example is an ert-butyl group.
【0042】アリール基としては、例えば、フェニル
基、ナフチル基等の置換または非置換の芳香族炭化水素
基が代表的である。芳香族複素環基としては、フリル
基、チエニル基、ピリジル基、ピロリル基、オキサゾリ
ル基、イソオキサゾル基、チアゾリル基、イソチアゾリ
ル基、イミダゾリル基、ピラゾリル基、ピリミジル基、
ピリダジニル基、ピラリジニル基、キノリル基、イソキ
ノリル基等が代表的である。Typical examples of the aryl group are substituted or unsubstituted aromatic hydrocarbon groups such as phenyl group and naphthyl group. The aromatic heterocyclic group, a furyl group, a thienyl group, a pyridyl group, a pyrrolyl group, an oxazolyl group, an isoxazole group, a thiazolyl group, an isothiazolyl group, an imidazolyl group, a pyrazolyl group, a pyrimidyl group,
Representative examples are a pyridazinyl group, a pyralidinyl group, a quinolyl group, an isoquinolyl group and the like.
【0043】また、2個のR4同士または2個のR5同士
は、相互に結合して環を形成していてもよく、例えば、
−(CH2)4−等の基を介して相互に結合して6員環等
の環を形成していてもよい。Further, two R 4 s or two R 5 s may be bonded to each other to form a ring.
They may be bonded to each other via a group such as — (CH 2 ) 4 — to form a ring such as a 6-membered ring.
【0044】さらに、R6、R7及びR8は、同一でも異
なっていてもよく、水素原子、直鎖もしくは分岐状のア
ルキル基、直鎖もしくは分岐状のアルケニル基、アリー
ル基、芳香族複素環基、アシル基、アルコキシカルボニ
ル基、アリールオキシカルボニル基、またはアラルキル
オキシカルボニル基であり、これらは置換基を有してい
てもよい。直鎖または分岐鎖状のアルキル基としては、
メチル基、エチル基、n−プロピル基、イソプロピル
基、n−ブチル基、sec−ブチル基、tert−ブチ
ル基等が代表的である。Further, R 6 , R 7 and R 8 may be the same or different and each is a hydrogen atom, a linear or branched alkyl group, a linear or branched alkenyl group, an aryl group or an aromatic heterocyclic group. It is a ring group, an acyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, or an aralkyloxycarbonyl group, which may have a substituent. As the linear or branched alkyl group,
Typical examples are methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, sec-butyl group and tert-butyl group.
【0045】直鎖もしくは分岐鎖状のアルケニル基とし
ては、ビニル基、2−プロペニル基が代表的である。ア
リール基としては、フェニル基、ナフチル基等の置換ま
たは非置換の芳香族炭化水素基が代表的である。芳香族
複素環基としては、フリル基、チエニル基、ピリジル
基、ピロリル基、オキサゾリル基、イソオキサゾル基、
チアゾリル基、イソチアゾリル基、イミダゾリル基、ピ
ラゾリル基、ピリミジル基、ピリダジニル基、ピラリジ
ニル基、キノリル基、イソキノリル基等の置換または非
置換の芳香族複素環基が代表的である。Typical linear or branched alkenyl groups are vinyl and 2-propenyl groups. As the aryl group, a substituted or unsubstituted aromatic hydrocarbon group such as a phenyl group and a naphthyl group is typical. As the aromatic heterocyclic group, a furyl group, a thienyl group, a pyridyl group, a pyrrolyl group, an oxazolyl group, an isoxazole group,
Representative examples are substituted or unsubstituted aromatic heterocyclic groups such as thiazolyl group, isothiazolyl group, imidazolyl group, pyrazolyl group, pyrimidyl group, pyridazinyl group, pyraridinyl group, quinolyl group and isoquinolyl group.
【0046】アシル基としては、アセチル基、トリフル
オロアセチル基、プロピオニル基、ブチリル基、イソブ
チリル基、ピバロイル基等の脂肪族アシル基、ベンゾイ
ル基、3,5−ジメチルベンゾイル基、2,4,6−ト
リメチルベンゾイル基、2,6−ジメトキシベンゾイル
基、2,4,6−トリメトキシベンゾイル基、2,6−
ジイソプロポキシベンゾイル基、1−ナフチルカルボニ
ル基、2−ナフチルカルボニル基、9−アントリルカル
ボニル基等の芳香族アシル基が代表的である。As the acyl group, an acetyl group, a trifluoroacetyl group, a propionyl group, a butyryl group, an isobutyryl group, a pivaloyl group or another aliphatic acyl group, a benzoyl group, a 3,5-dimethylbenzoyl group, 2,4,6 -Trimethylbenzoyl group, 2,6-dimethoxybenzoyl group, 2,4,6-trimethoxybenzoyl group, 2,6-
Aromatic acyl groups such as diisopropoxybenzoyl group, 1-naphthylcarbonyl group, 2-naphthylcarbonyl group and 9-anthrylcarbonyl group are typical.
【0047】アルコキシカルボニル基の代表例として
は、メトキシカルボニル基、エトキシカルボニル基、n
−ブトキシカルボニル基、n−オクチルオキシカルボニ
ル基、シクロペンチルオキシカルボニル基、シクロヘキ
シルオキシカルボニル基、シクロオクチルオキシカルボ
ニル基、tert−ブトキシカルボニル基が挙げられ
る。Typical examples of the alkoxycarbonyl group include methoxycarbonyl group, ethoxycarbonyl group, n
Examples include -butoxycarbonyl group, n-octyloxycarbonyl group, cyclopentyloxycarbonyl group, cyclohexyloxycarbonyl group, cyclooctyloxycarbonyl group and tert-butoxycarbonyl group.
【0048】アリールオキシカルボニル基の代表例とし
ては、フェノキシカルボニル基が挙げられる。アラルキ
ルオキシカルボニル基の代表例としては、ベンジルオキ
シカルボニル基、フェネチルオキシカルボニル基等が挙
げられる。A typical example of the aryloxycarbonyl group is a phenoxycarbonyl group. Representative examples of the aralkyloxycarbonyl group include a benzyloxycarbonyl group and a phenethyloxycarbonyl group.
【0049】また、R 6及びR7は、相互に連結して、
R6及びR7がそれぞれ結合している炭素原子と共同して
環を形成してもよい。例えば、R6及びR7が相互に連結
して、−(CH2)4−または−CH=CH−CH=CH
−となる場合、それぞれシクロヘキサン環またはベンゼ
ン環が形成され、このように形成されたシクロヘキサン
環、ベンゼン環等の環は、例えば、メチル基、エチル
基、n−プロピル基、イソプロピル基、n−ブチル基、
sec−ブチル基、tert−ブチル基等のアルキル
基、フェニル基、ナフチル基等のアリール基から選ばれ
る1または2以上の置換基で置換されていてもよく、ま
た、前記ベンゼン環は縮合し、ナフタレン環等の縮合多
環を形成してもよい。R 6 and R 7 are connected to each other,
R 6 and R 7 may form a ring together with the carbon atom to which they are bonded. For example, R 6 and R 7 are linked to each other, - (CH 2) 4 - or -CH = CH-CH = CH
In the case of-, a cyclohexane ring or a benzene ring is respectively formed, and the ring such as the cyclohexane ring or the benzene ring formed is, for example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, or an n-butyl group. Base,
sec-butyl group, alkyl group such as tert-butyl group, phenyl group, may be substituted with one or more substituents selected from aryl groups such as naphthyl group, the benzene ring is condensed, A condensed polycycle such as a naphthalene ring may be formed.
【0050】前記式(d)で表される光学活性コバルト
(II)錯体の具体例として、下記式(d−1)〜(d
−9)で表されるもの等が挙げられる。Specific examples of the optically active cobalt (II) complex represented by the above formula (d) include the following formulas (d-1) to (d).
-9) etc. are mentioned.
【0051】[0051]
【化19】 [Chemical 19]
【0052】[0052]
【化20】 [Chemical 20]
【0053】[0053]
【化21】 [Chemical 21]
【0054】[0054]
【化22】 [Chemical formula 22]
【0055】[0055]
【化23】 [Chemical formula 23]
【0056】[0056]
【化24】 [Chemical formula 24]
【0057】[0057]
【化25】 [Chemical 25]
【0058】[0058]
【化26】 [Chemical formula 26]
【0059】[0059]
【化27】 [Chemical 27]
【0060】また、本発明の方法において、前記一般式
(d)で表される光学活性コバルト(II)錯体から誘
導して得られる、次式(e):In the method of the present invention, the following formula (e) obtained by deriving from the optically active cobalt (II) complex represented by the above general formula (d):
【0061】[0061]
【化28】 [Chemical 28]
【0062】(式中、R4、R5、R6、R7、R8は前記
一般式(d)について定義したとおりであり、X-は、
塩を形成し得る陰イオン対を表す。)で表される光学活
性コバルト(III)錯体も、本発明の方法で用いる触
媒として有効である。(In the formula, R 4 , R 5 , R 6 , R 7 and R 8 are as defined for the general formula (d), and X − is
Represents an anion pair capable of forming a salt. The optically active cobalt (III) complex represented by the formula (4) is also effective as a catalyst used in the method of the present invention.
【0063】この一般式(e)において、X-として
は、F-、Cl-、Br-、I-、OH-、CH3CO2 -、p
−CH3C6H4SO3 -、CF3SO3 -、PF6 -、BF4 -、
BPh4 -、SbF6 -、ClO4 -等が代表的である。In this general formula (e), X-As
Is F-, Cl-, Br-, I-, OH-, CH3CO2 -, P
-CH3C6HFourSO3 -, CF3SO3 -, PF6 -, BFFour -,
BPhFour -, SbF6 -, ClOFour -Etc. are typical.
【0064】前記式(e)で表される光学活性コバルト
(III)錯体の具体例として、下記式(e−1)〜
(e−3)で表されるもの等が挙げられる。Specific examples of the optically active cobalt (III) complex represented by the above formula (e) include the following formulas (e-1) to (e-1).
The thing etc. which are represented by (e-3) are mentioned.
【0065】[0065]
【化29】 [Chemical 29]
【0066】[0066]
【化30】 [Chemical 30]
【0067】[0067]
【化31】 [Chemical 31]
【0068】本発明の方法において触媒として用いる前
記一般式(d)もしくは(e)で表される光学活性コバ
ルト錯体の使用量は、式(b)の化合物1モルに対して
0.01〜20モル%であり、より好ましくは0.5〜
10モル%である。The amount of the optically active cobalt complex represented by the general formula (d) or (e) used as a catalyst in the method of the present invention is 0.01 to 20 relative to 1 mol of the compound of the formula (b). Mol%, more preferably 0.5 to
It is 10 mol%.
【0069】本発明の方法において、ヒドリド試薬とし
ては、特開平9−151143号公報に開示されている
水素化アルミニウムリチウム、トリ(tert−ブトキ
シ)水素化アルミニウムリチウム、水素化ホウ素リチウ
ム、水素化ホウ素ナトリウム、水素化ホウ素カリウム、
水素化ホウ素カルシウム、水素化ホウ素アンモニウム、
水素化シアノホウ素ナトリウムなどの金属水素化物はい
ずれも使用することができるが、操作性の面で水素化ホ
ウ素ナトリウムが好ましい。In the method of the present invention, as the hydride reagent, lithium aluminum hydride, lithium aluminum tri (tert-butoxy) hydride, lithium borohydride, borohydride and borohydride disclosed in JP-A-9-151143 are used. Sodium, potassium borohydride,
Calcium borohydride, ammonium borohydride,
Although any metal hydride such as sodium cyanoborohydride can be used, sodium borohydride is preferable from the viewpoint of operability.
【0070】ヒドリド試薬の使用量は、式(b)の化合
物1モルに対して1〜10倍モル、好ましくは1〜2倍
モルの割合で用いればよい。本発明の方法において、添
加剤としてハロゲン化合物を用いると光学収率が向上す
る点で好ましい。The amount of the hydride reagent used may be 1 to 10 times mol, preferably 1 to 2 times mol, relative to 1 mol of the compound of the formula (b). In the method of the present invention, it is preferable to use a halogen compound as an additive because the optical yield is improved.
【0071】添加剤として用いるハロゲン化合物は、ト
リフルオロメチルベンゼン、ジクロロメタン、クロロホ
ルム、四塩化炭素、クロロエタン、1,2−ジクロロエ
タン、1,1,1−トリクロロエタン、ジクロロ酢酸メ
チル、塩化ベンジル、塩化ベンザル、ジブロモメタン、
ブロモホルム、四臭化炭素、ブロモエタン、1,2−ジ
ブロモエタン、ヨウ化メチル、ジヨードメタン、ヨード
ホルム、四ヨウ化炭素などが挙げられる。これらの中
で、高い光学収率及び高い化学収率で式(c)で表され
る化合物が得られる点で、ジクロロメタン、クロロホル
ム、四塩化炭素、1,1,1−トリクロロエタン、ブロ
モホルム、ヨードホルムが好ましい。The halogen compound used as an additive is trifluoromethylbenzene, dichloromethane, chloroform, carbon tetrachloride, chloroethane, 1,2-dichloroethane, 1,1,1-trichloroethane, methyl dichloroacetate, benzyl chloride, benzal chloride, Dibromomethane,
Examples thereof include bromoform, carbon tetrabromide, bromoethane, 1,2-dibromoethane, methyl iodide, diiodomethane, iodoform and carbon tetraiodide. Among them, dichloromethane, chloroform, carbon tetrachloride, 1,1,1-trichloroethane, bromoform and iodoform are preferable in that the compound represented by the formula (c) can be obtained with high optical yield and high chemical yield. preferable.
【0072】上記ハロゲン化合物を用いる場合の使用量
は、式(b)の化合物1モルに対して、0.001〜2
0倍モル、特に0.01〜10倍モルの割合で使用する
のが好ましい。上記ハロゲン化合物において、ジクロロ
メタン、クロロホルム、四塩化炭素等のハロゲン系溶媒
は、溶媒に用いても良い。本発明の方法において、添加
剤としてアルコール化合物を用いると光学収率が向上す
る点で好ましい。When the above halogen compound is used, the amount used is 0.001-2 with respect to 1 mol of the compound of the formula (b).
It is preferably used in an amount of 0 times mol, particularly 0.01 to 10 times mol. In the above halogen compound, a halogen-based solvent such as dichloromethane, chloroform, carbon tetrachloride or the like may be used as the solvent. In the method of the present invention, it is preferable to use an alcohol compound as an additive because the optical yield is improved.
【0073】アルコール化合物は特開平9−15114
3号公報に開示されているメタノール、エタノール、n
−プロパノール、iso−プロパノール、n−ブタノー
ル、sec−ブタノール、tert−ブタノール、シク
ロペンタノール、シクロヘキサノール、シクロヘプタノ
ール等の脂肪族または脂環式アルコール、フェノール、
レゾルシン等の芳香族アルコール、エチレングリコー
ル、プロピレングリコール等のポリアルコール、エチレ
ングリコールモノメチルエーテル、エチレングリコール
モノエチルエーテル、プロピレングリコールモノメチル
エーテル、テトラヒドロフルフリルアルコール、テトラ
ヒドロピラン−2−メタノール、フルフリルアルコー
ル、テトラヒドロ−3−フラン−メタノール等の鎖状ま
たは環状エーテルアルコールなどのアルコール化合物の
いずれも使用することができるが、本発明においては、
メタノール、エタノール、テトラヒドロフルフリルアル
コールが好ましい。Alcohol compounds are disclosed in JP-A-9-15114.
Methanol, ethanol, n disclosed in JP-A-3
-Propanol, iso-propanol, n-butanol, sec-butanol, tert-butanol, cyclopentanol, cyclohexanol, cycloheptanol or other aliphatic or alicyclic alcohol, phenol,
Aromatic alcohols such as resorcin, polyalcohols such as ethylene glycol and propylene glycol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, propylene glycol monomethyl ether, tetrahydrofurfuryl alcohol, tetrahydropyran-2-methanol, furfuryl alcohol, tetrahydro Any chain or cyclic ether alcohol such as -3-furan-methanol can be used, but in the present invention,
Preferred are methanol, ethanol and tetrahydrofurfuryl alcohol.
【0074】その使用量は、式(b)の化合物1モルに
対して、0.01〜100倍モル、特に0.1〜50倍
モルの割合で使用するのが好ましい。The amount used is preferably 0.01 to 100 times mol, particularly 0.1 to 50 times mol, relative to 1 mol of the compound of the formula (b).
【0075】また、本発明の方法において、前記反応
は、好ましくは液相中で行われる。この時、必要に応じ
て溶媒を使用することができる。用いる溶媒としては、
特開平9−151143号公報に開示されている脂肪族
炭化水素系溶媒、エーテル系溶媒、芳香族炭化水素系溶
媒、脂環式炭化水素系溶媒、エステル系溶媒、およびハ
ロゲン系溶媒などの溶媒はいずれも使用することができ
るが、テトラヒドロフラン等のエーテル系溶媒、トルエ
ン等の芳香族炭化水素系溶媒、あるいは酢酸エチル等の
エステル系溶媒が好ましい。In the method of the present invention, the reaction is preferably carried out in the liquid phase. At this time, a solvent may be used if necessary. The solvent used is
Solvents such as aliphatic hydrocarbon solvents, ether solvents, aromatic hydrocarbon solvents, alicyclic hydrocarbon solvents, ester solvents, and halogen solvents disclosed in JP-A-9-151143 are Any of these can be used, but ether solvents such as tetrahydrofuran, aromatic hydrocarbon solvents such as toluene, and ester solvents such as ethyl acetate are preferable.
【0076】反応温度は、通常、−80〜30℃が好ま
しく、さらに、−40〜10℃が好ましい。反応圧力
は、通常、常圧で行うことができるが、加圧または減圧
下に反応を行ってもよい。また、反応時間は、通常、1
0分から2時間程度である。反応は、逐次、反応混合物
のサンプルを採取して、薄層クロマトグラフィー(TL
C)等により分析して、反応の進行状況を確認すること
ができる。The reaction temperature is usually preferably -80 to 30 ° C, more preferably -40 to 10 ° C. The reaction pressure can be usually atmospheric pressure, but the reaction may be performed under increased pressure or reduced pressure. The reaction time is usually 1
It is from 0 minutes to 2 hours. For the reaction, samples of the reaction mixture were sequentially taken and subjected to thin layer chromatography (TL
The progress of the reaction can be confirmed by analyzing C) or the like.
【0077】以上の反応によって得られる式(c)の化
合物の精製は、公知の方法、例えば、カラムクロマトグ
ラフィーによる方法、抽出、再結晶等の方法を組み合わ
せて行うことができる。The compound of formula (c) obtained by the above reaction can be purified by a combination of known methods such as column chromatography, extraction and recrystallization.
【0078】[0078]
【実施例】以下、実施例により本発明を具体的に説明す
るが、本発明は、これらの実施例に限定されるものでは
ない。なお、本実施例においては、シリカゲルクロマト
グラフィーには、メルク社製No.9385のシリカゲ
ルを使用した。EXAMPLES The present invention will now be described in detail with reference to examples, but the present invention is not limited to these examples. In this example, the silica gel chromatography was performed by Merck No. 9385 silica gel was used.
【0079】(実施例1)反応器に4−(4−ヘキサノ
イルフェニル)酪酸メチル4.7g (17mmol)、
ヒドロキシアミン塩酸塩1.8g(25mmol)を入
れ、メタノール20mlを加えた。反応溶液に室温でト
リエチルアミン2g(25mol)を滴下した後、その
温度で3時間攪拌した。反応溶液を減圧濃縮後、水を加
えて酢酸エチル50mlで抽出を行った。有機層を硫酸
ナトリウムで乾燥し、硫酸ナトリウムを濾去後、減圧濃
縮した。濃縮液をシリカゲルカラムクロマトグラフィ−
(ヘキサン/酢酸エチル= 5/1)で分離精製する
と、 4−[4−(1−ヒドロキシイミノヘキシル)フ
ェニル]酪酸メチル4.4g(15mmol)が得られ
た。Example 1 Methyl 4- (4-hexanoylphenyl) butyrate (4.7 g, 17 mmol) was added to a reactor.
1.8 g (25 mmol) of hydroxyamine hydrochloride was added, and 20 ml of methanol was added. After 2 g (25 mol) of triethylamine was added dropwise to the reaction solution at room temperature, the mixture was stirred at that temperature for 3 hours. The reaction solution was concentrated under reduced pressure, water was added, and the mixture was extracted with 50 ml of ethyl acetate. The organic layer was dried over sodium sulfate, the sodium sulfate was filtered off, and the filtrate was concentrated under reduced pressure. Silica gel column chromatography
By separating and purifying with (hexane / ethyl acetate = 5/1), 4.4 g (15 mmol) of methyl 4- [4- (1-hydroxyiminohexyl) phenyl] butyrate was obtained.
【0080】(実施例2)反応器に4−[4−(1−ヒ
ドロキシイミノヘキシル)フェニル]酪酸メチル2g
(6.9mmol)をいれ、窒素置換し四塩化炭素5m
lを加えた。続いて、トリエチルアミン3.8ml(2
8mmol)を滴下後、反応溶液を0℃に冷やした。反
応溶液中にパラトルエンスルホニルシアニド2.5g
(13.8mmol)の四塩化炭素溶液8mlを滴下
し、その温度で1時間攪拌した。その後、室温まで温度
を上げ、室温で2時間攪拌した。その後、水を15ml
加え、ジクロロメタン30mlで抽出を行った。有機層
を硫酸ナトリウムで乾燥し、硫酸ナトリウムを濾去後、
減圧濃縮した。濃縮液をシリカゲルカラムクロマトグラ
フィ−(ヘキサン/酢酸エチル= 3/1)で分離精製
すると、4−[4−(1−パラトルエンスルホニルイミ
ノヘキシル)フェニル]酪酸メチル1.5g(3.5m
mol)が得られた。(Example 2) 2 g of methyl 4- [4- (1-hydroxyiminohexyl) phenyl] butyrate in a reactor
Add (6.9 mmol), replace with nitrogen and carbon tetrachloride 5m
1 was added. Then, 3.8 ml of triethylamine (2
(8 mmol) was added dropwise, and the reaction solution was cooled to 0 ° C. 2.5 g of paratoluenesulfonyl cyanide in the reaction solution
8 ml of a carbon tetrachloride solution of (13.8 mmol) was added dropwise, and the mixture was stirred at that temperature for 1 hour. Then, the temperature was raised to room temperature, and the mixture was stirred at room temperature for 2 hours. Then, 15 ml of water
In addition, extraction was performed with 30 ml of dichloromethane. The organic layer is dried over sodium sulfate, the sodium sulfate is filtered off,
It was concentrated under reduced pressure. The concentrate was separated and purified by silica gel column chromatography (hexane / ethyl acetate = 3/1) to give methyl 4- [4- (1-paratoluenesulfonyliminohexyl) phenyl] butyrate (1.5 g, 3.5 m).
mol) was obtained.
【0081】(実施例3)反応器に水素化ホウ素ナトリ
ウム13mg (0.35mmol)を入れ、窒素置換
し、テトラヒドロフラン1mlを加え、−10℃に冷却
した。別容器に式(d−6)で表される(S,S)の立
体配置を有する光学活性コバルト(II)錯体1.3m
g (0.0023mmol、基質に対して1mol
%)、4−[4−(1−パラトルエンスルホニルイミノ
ヘキシル)フェニル]酪酸メチル100mg (0.2
3mmol)を入れ、窒素置換し、メタノール28μl
(0.7mmol)、クロロホルム18μl (0.2
3mmol) 及びテトラヒドロフラン1mlを加え、
溶液を調製した。その調製溶液をシリンジに取り、-10
℃に冷やしておいた水素化ホウ素ナトリウム/テトラヒ
ドロフラン懸濁液中に滴下し、−10℃で10分攪拌し
た。その後、食塩水を2ml加え、酢酸エチル15ml
で抽出を行った。有機層を硫酸ナトリウムで乾燥し、硫
酸ナトリウムを濾去後、減圧濃縮した。濃縮液をシリカ
ゲルカラムクロマトグラフィ−(ヘキサン/酢酸エチル
=4/1)で分離精製すると、4−[4−(1−パラト
ルエンスルホニルアミノヘキシル)フェニル]酪酸メチ
ル90mg(0.21mmol)が得られた。本品の光
学純度はHPLC分析により43%eeと決定した。(Example 3) 13 mg (0.35 mmol) of sodium borohydride was placed in the reactor, the atmosphere was replaced with nitrogen, 1 ml of tetrahydrofuran was added, and the mixture was cooled to -10 ° C. Optically active cobalt (II) complex having the configuration of (S, S) represented by formula (d-6) in a separate container 1.3 m
g (0.0023 mmol, 1 mol relative to the substrate)
%), Methyl 4- [4- (1-paratoluenesulfonyliminohexyl) phenyl] butyrate 100 mg (0.2
3 mmol) and nitrogen substitution, methanol 28 μl
(0.7 mmol), 18 μl of chloroform (0.2
3 mmol) and 1 ml of tetrahydrofuran,
A solution was prepared. Take the prepared solution in a syringe and
The mixture was added dropwise to a sodium borohydride / tetrahydrofuran suspension that had been cooled to ° C, and the mixture was stirred at -10 ° C for 10 minutes. Then, add 2 ml of saline, and add 15 ml of ethyl acetate.
It was extracted with. The organic layer was dried over sodium sulfate, the sodium sulfate was filtered off, and the filtrate was concentrated under reduced pressure. The concentrated liquid was separated and purified by silica gel column chromatography (hexane / ethyl acetate = 4/1) to obtain 90 mg (0.21 mmol) of methyl 4- [4- (1-paratoluenesulfonylaminohexyl) phenyl] butyrate. . The optical purity of this product was determined to be 43% ee by HPLC analysis.
【0082】HPLC測定条件
使用カラム:CHIRALPAK OD−H φ4.6mm
X 250mm(ダイセル化学工業社製)
移動相:ヘキサン/2−プロパノール=90/10
カラム温度 : 35℃
流速 : 0.8ml/分
検出波長 : 220nmColumns used for HPLC measurement conditions: CHIRALPAK OD-H φ4.6 mm
X 250 mm (manufactured by Daicel Chemical Industries, Ltd.) Mobile phase: Hexane / 2-propanol = 90/10 Column temperature: 35 ° C Flow rate: 0.8 ml / min Detection wavelength: 220 nm
【0083】(実施例4〜5)各例において、式(d−
6)で表されるコバルト触媒の種類を表1に示す触媒に
変更した以外は、実施例3と同様にして反応を行った。
いずれの例においても定量的に4−[4−(1−パラト
ルエンスルホニルアミノヘキシル)フェニル]酪酸メチ
ルが得られた。得られた生成物の光学純度を分析した結
果を表1に示す。(Examples 4 to 5) In each example, the formula (d-
The reaction was performed in the same manner as in Example 3 except that the type of the cobalt catalyst represented by 6) was changed to the catalyst shown in Table 1.
In each of the examples, methyl 4- [4- (1-paratoluenesulfonylaminohexyl) phenyl] butyrate was quantitatively obtained. The results of analyzing the optical purity of the obtained product are shown in Table 1.
【0084】[0084]
【表1】 [Table 1]
【0085】[0085]
【発明の効果】本発明の方法によれば、ケトン化合物か
ら少ない工程数かつ簡便な方法で、スルホンアミド化合
物をエナンチオ選択的に製造することができる。スルホ
ンアミド化合物は医薬品農薬等の生理活性化合物の合成
中間体として有用である。According to the method of the present invention, a sulfonamide compound can be produced enantioselectively from a ketone compound with a small number of steps and a simple method. The sulfonamide compound is useful as a synthetic intermediate for bioactive compounds such as pharmaceuticals and agricultural chemicals.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C07M 7:00 C07M 7:00 Fターム(参考) 4G069 AA06 AA08 BA27A BA27B BC67A BC67B BE13A BE13B BE36A BE36B CB02 DA02 FA01 4H006 AA02 AC61 AC81 BA20 BA32 BA46 BA61 BE23 4H039 CA99 CB30 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) C07M 7:00 C07M 7:00 F term (reference) 4G069 AA06 AA08 BA27A BA27B BC67A BC67B BE13A BE13B BE36A BE36B CB02 DA02 FA01 4H006 AA02 AC61 AC81 BA20 BA32 BA46 BA61 BE23 4H039 CA99 CB30
Claims (4)
ルキル基、1個または複数個のフッ素原子が置換した炭
素数4〜8の直鎖状または分岐鎖状のアルキル基を表
し、R2は水素原子または低級アルキル基を表す。)で
示されるケトン化合物をスルホニル化して、式(b): 【化2】 (式中、R1及びR2は式(a)と同様の基を表す。R3
は水素原子、ハロゲン原子、低級アルキル基、低級アル
コキシ基またはニトロ基を表す。)で示されるスルホン
イミド化合物に導いた後、不斉還元して、式(c): 【化3】 (式中、R1、R2及びR3は式(a)及び式(b)と同
様の基を表す。)で示される光学活性なスルホンアミド
化合物を製造する方法。1. Formula (a): (In the formula, R 1 is a linear or branched alkyl group having 4 to 8 carbon atoms, or a linear or branched alkyl group having 4 to 8 carbon atoms substituted with one or more fluorine atoms. R 2 represents a hydrogen atom or a lower alkyl group), and the ketone compound represented by the formula (b): (In the formula, R 1 and R 2 represent the same groups as in the formula (a). R 3
Represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group or a nitro group. ), And then asymmetrically reduced to give a sulfonimide compound represented by the formula (c): (In the formula, R 1 , R 2 and R 3 represent the same groups as those in the formulas (a) and (b).) A method for producing an optically active sulfonamide compound.
において、式(b)で示される化合物を、光学活性コバ
ルト錯体触媒およびヒドリド試薬の存在下に不斉ヒドリ
ド還元し、式(c)で示される光学活性なスルホンアミ
ド化合物に変換することを特徴とする請求項1記載の方
法。2. In the step of producing a compound represented by the formula (c), the compound represented by the formula (b) is subjected to asymmetric hydride reduction in the presence of an optically active cobalt complex catalyst and a hydride reagent, ) The method according to claim 1, which comprises converting to an optically active sulfonamide compound represented by the formula (1).
般式(d): 【化4】 もしくは一般式(e): 【化5】 (一般式(d)及び(e)において、R4とR5は異な
る基であり、それぞれ、水素原子、直鎖もしくは分岐鎖
状のアルキル基、アリール基または芳香族複素環基であ
り、これらは置換基を有していてもよく、2個の R4
同士または2個のR5同士は、相互に結合して環を形成
していてもよく、また、R6、R7及びR 8は、同一で
も異なっていてもよく、水素原子、直鎖または分岐鎖状
のアルキル基、直鎖もしくは分岐鎖状のアルケニル基、
アリール基、芳香族複素環基、アシル基、アルコキシカ
ルボニル基、アリールオキシカルボニル基またはアラル
キルオキシカルボニル基であり、これらは置換基を有し
ていてもよい。R6及びR7は、相互に連結してR6及
びR7がそれぞれ結合している炭素原子と共同して環を
形成してもよく、環はアルキル基及びアリール基から選
ばれる少なくとも一つの基で置換されていてもよい。X
-は、塩を形成し得る陰イオン対を表す。)で表される
化合物であることを特徴とする請求項2記載の方法。3. The optically active cobalt complex catalyst is one of the following:
General formula (d): [Chemical 4] Or general formula (e): [Chemical 5] (In the general formulas (d) and (e), RFourAnd R5Is different
A hydrogen atom, a straight chain or a branched chain, respectively.
-Like alkyl group, aryl group or aromatic heterocyclic group
And these may have a substituent, two RFour
Two or two R5Each other bonds to each other to form a ring
R may6, R7And R 8Are the same
May be different, and may be a hydrogen atom, straight chain or branched chain
Alkyl group, linear or branched alkenyl group,
Aryl group, aromatic heterocyclic group, acyl group, alkoxy group
Rubonyl group, aryloxycarbonyl group or aral
Is a cycloalkyloxy group, which has a substituent
May be. R6And R7Are connected to each other by R6Over
And R7Together with the carbon atom to which
It may be formed and the ring is selected from alkyl and aryl groups.
It may be substituted with at least one group selected from the group consisting of: X
-Represents an anion pair capable of forming a salt. )
The method according to claim 2, which is a compound.
リド試薬として水素化ホウ素ナトリウムを使用すること
を特徴とする、請求項2ないし3記載の製造方法。4. The method according to claim 2, wherein sodium borohydride is used as a hydride reagent in the asymmetric hydride reduction reaction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002082509A JP2003277346A (en) | 2002-03-25 | 2002-03-25 | Method for producing optically active sulfonamide compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002082509A JP2003277346A (en) | 2002-03-25 | 2002-03-25 | Method for producing optically active sulfonamide compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003277346A true JP2003277346A (en) | 2003-10-02 |
Family
ID=29230669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002082509A Pending JP2003277346A (en) | 2002-03-25 | 2002-03-25 | Method for producing optically active sulfonamide compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003277346A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214262A (en) * | 2007-03-03 | 2008-09-18 | Japan Science & Technology Agency | Process for producing optically active sulfonylimine compound |
-
2002
- 2002-03-25 JP JP2002082509A patent/JP2003277346A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214262A (en) * | 2007-03-03 | 2008-09-18 | Japan Science & Technology Agency | Process for producing optically active sulfonylimine compound |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003277346A (en) | Method for producing optically active sulfonamide compound | |
US7049455B2 (en) | Process for producing shogaols and intermediates for the synthesis thereof | |
JP2003313153A (en) | Method for producing optically active 2-acylated 1,2-diol compound derivative | |
JP3338227B2 (en) | Method for producing ketonitrile derivative and hexenone derivative | |
JPS60172975A (en) | Production of erythro-3-(3,4-methylenedioxyphenyl)-serine | |
JP2006520351A (en) | Method for producing cyanoisobenzofuran | |
JP2000169407A (en) | Production of 3-butene-1-ol derivative | |
FR2781479A1 (en) | SULFONES AND PROCESS FOR THEIR PREPARATION | |
JP4918736B2 (en) | Novel optically active ruthenium complex, process for producing the same, and process for producing optically active compounds using the same | |
JP2003252849A (en) | Method for producing optically active sulfonamide | |
JP2001261595A (en) | Method for producing optically active 1,3-propanediols | |
JP3056360B2 (en) | Production method of γ-coronal | |
JPH0840971A (en) | Production of hinokitiol and its intermediate product | |
JP3272340B2 (en) | Method for producing 1-[(cyclopent-3-en-1-yl) methyl] -5-ethyl-6- (3,5-dimethylbenzoyl) -2,4-pyrimidinedione | |
JPS6197251A (en) | Production of 3-(2,2-diemthyl-3-alkyl-6-methylenecyclohexyl)-acarylonitrile | |
JP2002265467A (en) | Optically active thiacalixarene derivative and method for producing the same | |
JP3065199B2 (en) | Method for producing 2- (furfurylthio) acetic acid derivative | |
JP2545289B2 (en) | Method for producing γ-ionones | |
CN117946039A (en) | Chiral synthesis process of englitz intermediate | |
JPH023630A (en) | 2,6-diethyl-4-iodoaniline and production thereof | |
JPH0489441A (en) | Production of optically active 2-alkanol | |
JPH0967292A (en) | Method for producing benzaldehyde derivative | |
EP0374014A2 (en) | Organo-manganese compounds, their preparation and their use | |
JPS601145A (en) | Optically active propargyl alcohol derivatives and optical resolution agents | |
JPS60126280A (en) | Production of optically active epichlorohydrin |